Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bryskier

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Antimicrobial Chemotherapy|May 1, 2004
Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/6J miceL Törmäkangas, E Saario, D Bem David, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1990
Pharmacokinetics of cefodizime in elderly patients with moderate or severe renal impairmentP Veyssier, A Devillers, Y Domart, et al.
Drugs|January 1, 1987
Diffusion of ofloxacin into human lung tissueL Couraud, J B Fourtillan, M C Saux, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1995
Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteersB Lenfant, F Namour, C Logeais, et al.
Infection|January 1, 1986
[Diffusion of ofloxacin in human lung tissue]L Couraud, J B Fourtillan, M C Saux, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 1998
In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimensF Soriano, R Fernández-Roblas, R Calvo, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infectionF G Araujo, A A Khan, T L Slifer, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1992
Antibacterial activity of RU44790, a new N-tetrazolyl monocyclic beta-lactamJ F Chantot, M Klich, G Teutsch, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factorsP Bemer-Melchior, M E Juvin, S Tassin, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre studyC J Soussy, M Cluzel, M C Ploy, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Antimicrobial Chemotherapy|May 1, 2004
Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/6J miceL Törmäkangas, E Saario, D Bem David, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1990
Pharmacokinetics of cefodizime in elderly patients with moderate or severe renal impairmentP Veyssier, A Devillers, Y Domart, et al.
Drugs|January 1, 1987
Diffusion of ofloxacin into human lung tissueL Couraud, J B Fourtillan, M C Saux, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1995
Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteersB Lenfant, F Namour, C Logeais, et al.
Infection|January 1, 1986
[Diffusion of ofloxacin in human lung tissue]L Couraud, J B Fourtillan, M C Saux, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 1998
In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimensF Soriano, R Fernández-Roblas, R Calvo, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infectionF G Araujo, A A Khan, T L Slifer, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1992
Antibacterial activity of RU44790, a new N-tetrazolyl monocyclic beta-lactamJ F Chantot, M Klich, G Teutsch, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factorsP Bemer-Melchior, M E Juvin, S Tassin, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre studyC J Soussy, M Cluzel, M C Ploy, et al.
Pageof 11